carbamates has been researched along with Thalassemia in 2 studies
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharara, AI | 1 |
| Rustom, LBO | 1 |
| Marrache, M | 1 |
| Rimmani, HH | 1 |
| Bou Daher, H | 1 |
| Koussa, S | 1 |
| Taher, A | 1 |
| Honig, GR | 1 |
1 review available for carbamates and Thalassemia
| Article | Year |
|---|---|
Hemoglobinopathies and thalassemias. Abnormalities of hemoglobin structure, function, and synthesis.
Topics: Amino Acid Sequence; Amino Acids; Anemia, Sickle Cell; Biological Transport; Blood Transfusion; Carb | 1974 |
1 trial available for carbamates and Thalassemia
| Article | Year |
|---|---|
Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia.
Topics: Antiviral Agents; Blood Transfusion; Carbamates; Female; Hepatitis C, Chronic; Heterocyclic Compound | 2019 |